Prices delayed by at least 15 minutes | Print


Allergy Therapeutics PLC (AGY)

ORD 0.1P
Sell: 2.8p|Buy: 3.2p|Change: 0.20 (-6.67%)

Open 

3p


Previous close 

3p


Trade high 

3.2p


Volume 

120,404


Year high 

3.20p


Year low 

0.37p


Dividend yield 

-


Market capitalisation 

£133.46 mn


P/E ratio 

49.50


ISIN 

GB00B02LCQ05


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Allergy Therapeutics PLC+ 11.11
More...

Company profile

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202403:40:242.8621.74
28/03/202403:40:243.299731.90
28/03/202403:40:242.849713.92
28/03/202403:40:243.249715.90
28/03/202403:40:242.8782.18

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.